AR101 Real-World Open-Label Extension Study
Clinical trial NCT03337542 · COMPLETED
Trial details
- NCT number
- NCT03337542
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2019-09-20
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.